| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $344.6M | +32.7% |
| R&D Expense | $32.8M | +11.9% |
| SG&A Expense | $114.7M | +42.7% |
| Operating Income | $92.6M | +67.0% |
| Pre-tax Income | -$118.3M | -128.6% |
| Income Tax | $12.7M | +216.0% |
| Net Income | -$131.0M | -134.9% |
| EPS (Basic) | -$0.74 | -131.3% |
| EPS (Diluted) | -$0.74 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.2M | +114.3% |
| Accounts Receivable | $49.6M | +46.3% |
| Current Assets | $117.0M | +63.0% |
| Total Assets | $479.1M | +7.8% |
| Current Liabilities | $67.8M | +11.8% |
| Long-term Debt | $290.6M | -14.7% |
| Total Liabilities | $610.7M | +31.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $95.0M | +162.7% |
| Capital Expenditures | $945K | +85.7% |
| Investing Cash Flow | -$5.3M | -26.4% |
| Financing Cash Flow | -$58.9M | -351.5% |
| Free Cash Flow | $94.0M | +163.8% |
| -131.3% |
| Stockholders' Equity |
| -$131.6M |
| -619.3% |